Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dasiglucagon for Hypoglycemia Rescue in Pediatric T1D (<6 Years)
NCT05378672Phase 3Completed
- Sponsor
- Zealand Pharma
- Start
- May 2023
- Primary completion
- Oct 2024
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of dasiglucagon in hypoglycemia, sponsored by Zealand Pharma. Started May 2023; status: completed.
02
Drugs
dasiglucagon
03
Conditions
hypoglycemia
Beyond the preview
Go deeper on NCT05378672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05378672.